Brief: Bridge Biotherapeutics To Conduct Capital Increase Of 2 Billion Won For Operational Funds
12/01/2024 07:58
Bridge Biotherapeutics Inc 288330.KQ :
* BRIDGE BIOTHERAPEUTICS: TO CONDUCT CAPITAL INCREASE OF 2
BILLION
WON FOR OPERATIONAL FUNDS
Source text for Eikon: ID:
Further company coverage: 288330.KQ
Recent news on Parataxis Korea
See all newsBrief: Parataxis, Bridge Biotherapeutics Ink Deal to List Bitcoin Treasury Firm on Korea's KOSDAQ
Brief: Bridge Biotherapeutics Announces Completion Of Enrollment In The Phase 2A Clinical Study Of BBT-877 For The Treatment Of Idiopathic Pulmonary Fibrosis
Brief: Bridge Biotherapeutics Launches A Research Collaboration With Emory University School Of Medicine
Brief: Bridge Biotherapeutics Announces A Research Collaboration With The University Of Colorado School Of Medicine
Brief: Bridge Biotherapeutics To Conduct Capital Increase Of 2 Billion Won For Operational Funds